| __timestamp | Alpine Immune Sciences, Inc. | Biogen Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 2232342000 |
| Thursday, January 1, 2015 | 6844000 | 2113100000 |
| Friday, January 1, 2016 | 8586000 | 1947900000 |
| Sunday, January 1, 2017 | 6079000 | 1935500000 |
| Monday, January 1, 2018 | 8362000 | 2106300000 |
| Tuesday, January 1, 2019 | 9467000 | 2374700000 |
| Wednesday, January 1, 2020 | 10899000 | 2504500000 |
| Friday, January 1, 2021 | 14560000 | 2674300000 |
| Saturday, January 1, 2022 | 17968000 | 2403600000 |
| Sunday, January 1, 2023 | 22222000 | 2549700000 |
| Monday, January 1, 2024 | 2403700000 |
Unleashing the power of data
In the competitive world of biotechnology, understanding financial trends is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Biogen Inc. and Alpine Immune Sciences, Inc. from 2014 to 2023. Biogen, a giant in the industry, consistently reported SG&A expenses over $2 billion annually, peaking at $2.67 billion in 2021. In contrast, Alpine Immune Sciences, a smaller player, showed a steady increase from $2.3 million in 2014 to $22.2 million in 2023, marking a tenfold rise. This stark contrast highlights the scale and operational differences between established and emerging biotech firms. While Biogen's expenses reflect its expansive operations, Alpine's growth trajectory underscores its strategic investments in scaling operations. This financial snapshot offers insights into how these companies allocate resources to maintain competitiveness and drive innovation.
Johnson & Johnson and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared
Merck & Co., Inc. or Alpine Immune Sciences, Inc.: Who Manages SG&A Costs Better?
Amgen Inc. and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Cost Management Insights: SG&A Expenses for Biogen Inc. and BeiGene, Ltd.
Biogen Inc. vs CymaBay Therapeutics, Inc.: SG&A Expense Trends
Biogen Inc. and MannKind Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Biogen Inc. vs Novavax, Inc.
Biogen Inc. and BioCryst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Alpine Immune Sciences, Inc. vs Agios Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Alpine Immune Sciences, Inc. or Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Evotec SE